BORENAR 6 mg/ml Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

borenar 6 mg/ml

famar health care services madrid s.a.u. - spania - bilastinum - pic. oft., sol. - 6mg/ml - decongestionante si antialergice alte antialergice

ASTHALIN INHALER 100µg/doza Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

asthalin inhaler 100µg/doza

cipla (eu) limited - romania - salbutamolum - susp. inhal. presurizata - 100µg/doza - adrenergice inhalatorii agonisti selectivi ai receptorilor beta-2 adrenergici

EPIPEN 150 micrograme Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

epipen 150 micrograme

meda pharma gmbh & co.kg - germania - epinephrinum - sol inj. in stilou preumplut - 150micrograme - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

EPIPEN 300 micrograme Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

epipen 300 micrograme

meda pharma gmbh & co.kg - germania - epinephrinum - sol inj. in stilou preumplut - 300micrograme - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

EPIPEN 150 micrograme Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

epipen 150 micrograme

meda pharma gmbh & co.kg - germania - epinephrinum - sol. inj. in stilou preumplut - 150micrograme - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

EPIPEN 300 micrograme Romania - rumeno - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

epipen 300 micrograme

meda pharma gmbh & co.kg - germania - epinephrinum - sol. inj. in stilou preumplut - 300micrograme - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

Palforzia Unione Europea - rumeno - EMA (European Medicines Agency)

palforzia

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.